Mayo Clinic researchers found a new way kidneys manage water. This discovery uses an old drug, probenecid, to reveal a pathway independent of vasopressin. This could lead to better treatments for polycystic kidney disease. The drug reduced urine volume in trials, improving patient quality of life. Scientists now aim to develop targeted therapies based on this mechanism.